SCHEMBL24310807

SCHEMBL24310807

CCCc1c(Oc2ccccc2C)nc(NSc2cnn(C)c2)nc1-c1ccccc1C

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310383 0.93 KDM5A (0.32) —
SCHEMBL24309830 0.87 IGF1R (0.32) —
SCHEMBL24309901 0.85 IGF1R (0.33) —
SCHEMBL24309917 0.85 MAPK14 (0.33) —
SCHEMBL24310179 0.85 IGF1R (0.31) —
SCHEMBL24310360 0.84 KDM4E (0.33) —
SCHEMBL24310590 0.84 IGF1R (0.31) —
SCHEMBL24309378 0.83 IGF1R (0.30) —
SCHEMBL24309438 0.83 GABRG2 (0.30) —
SCHEMBL24310417 0.83 LMNA (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback